ScholarIQanswers from OpenAlex

Serum KL‐6 concentrations as a novel biomarker of severe COVID‐19

PaperCitations, authors & open-access status

Serum KL‐6 concentrations as a novel biomarker of severe COVID‐19 is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Serum KL‐6 concentrations as a novel biomarker of severe COVID‐19 have?

ScholarIQcitation count

Serum KL‐6 concentrations as a novel biomarker of severe COVID‐19 has 100 citations in the OpenAlex counts ScholarIQ stores.

When was Serum KL‐6 concentrations as a novel biomarker of severe COVID‐19 published?

ScholarIQyear

Serum KL‐6 concentrations as a novel biomarker of severe COVID‐19 has 2020 year in the ScholarIQ index.

What is the open-access status of Serum KL‐6 concentrations as a novel biomarker of severe COVID‐19?

ScholarIQoa status

Serum KL‐6 concentrations as a novel biomarker of severe COVID‐19 has bronze oa status in the ScholarIQ index.

What is the DOI of Serum KL‐6 concentrations as a novel biomarker of severe COVID‐19?

ScholarIQdoi

The DOI for Serum KL‐6 concentrations as a novel biomarker of severe COVID‐19 is on the source record.

What is the PMID of Serum KL‐6 concentrations as a novel biomarker of severe COVID‐19?

ScholarIQpmid

The PMID for Serum KL‐6 concentrations as a novel biomarker of severe COVID‐19 is on the source record.

What is the OpenAlex record for Serum KL‐6 concentrations as a novel biomarker of severe COVID‐19?

ScholarIQopenalex

The OpenAlex for Serum KL‐6 concentrations as a novel biomarker of severe COVID‐19 is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial